Article, News
‘Above and beyond approved therapies’: How Prescient Therapeutics is at the forefront of cancer fighting
Prescient Therapeutics is on a mission to improve outcomes for cancer patients, and it is making progress with a diverse portfolio of later and early-stage…
News
Prescient data readout approaching with phase 2 trial around the corner
Prescient Therapeutics (ASX: PTX) had a solid FY23 that has set the stage for a pivotal year to come. Front and centre of the company’s…
Article, News
Prescient Therapeutics (ASX:PTX) – TechKnow Invest Roadshow, August 2023
Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted…
Article, News
Strong quarter for Prescient bolsters future of further trials
Clinical stage oncology company Prescient Therapeutics Ltd (ASX: PTX) has finished off another strong quarter with a healthy $21.8 million cash balance that will serve…
Article, News
TechKnow Invest Roadshow
Hear Prescient Therapeutics (ASX: PTX) CEO and Managing Director Steven Yatomi-Clarke present at the TechKnow Invest Roadshow – Gold Coast.
Article, News
ASX Quarterly Wrap: Dimerix sees strong kidney drug trial recruitment, Prescient advances cancer therapy
It’s the quarterly season again as the ASX market announcements page becomes increasingly flooded with update lodgements. To save you the trouble of trudging through…
Article, News
Health Kick Podcast: Prescient Therapeutics an emerging global leader in the next generation of personalised cancer therapies.
Stockhead’s resident health and biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast. …
Article, News
Global Victoria HealthTech Talks – Regenerative Medicine
Victoria has a mature, internationally recognised and thriving ecosystem that supports research and translation of new Regenerative Medicine therapeutics for global markets. The field of…
Article, News
Prescient Therapeutics seeks to provide new tools for clinicians in combating cancer
The prestigious International Society of Cell and Gene Therapy (ISCT) will showcase two abstracts from Prescient Therapeutics Ltd (ASX:PTX) at its annual meeting in Paris, which runs…